{"id":"https://openalex.org/W1970758463","doi":"https://doi.org/10.1517/13543784.2014.848852","title":"Novel investigational agents for the treatment of scleroderma","display_name":"Novel investigational agents for the treatment of scleroderma","publication_year":2013,"publication_date":"2013-11-22","ids":{"openalex":"https://openalex.org/W1970758463","doi":"https://doi.org/10.1517/13543784.2014.848852","mag":"1970758463","pmid":"https://pubmed.ncbi.nlm.nih.gov/24261610"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.2014.848852","doi":"https://doi.org/10.1517/13543784.2014.848852","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2014.848852","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040906895","display_name":"Zsuzsanna Hortobagyi McMahan","orcid":"https://orcid.org/0000-0001-6461-8940","observed_orcids":["https://orcid.org/0000-0001-6461-8940"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zsuzsanna Hortobagyi McMahan","raw_affiliation_strings":["Johns Hopkins University, Medicine/Rheumatology , 55200 Eastern Avenue, MFL Center Tower, Suite 5300, Baltimore, MD 21224 , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Medicine/Rheumatology , 55200 Eastern Avenue, MFL Center Tower, Suite 5300, Baltimore, MD 21224 , USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068528030","display_name":"Fredrick M. Wigley","orcid":"https://orcid.org/0000-0003-0762-6981","observed_orcids":["https://orcid.org/0000-0003-0762-6981"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fredrick M Wigley","raw_affiliation_strings":["Johns Hopkins University, Medicine/Rheumatology, 55200 Eastern Avenue, MFL Center Tower, Suite 4100, Baltimore, MD 21224, USA +1 410 550 2003; +1 410 550 2072; fwig@jhmi.edu","+1 410 550 2072","Johns Hopkins University, Medicine/Rheumatology,\n55200 Eastern Avenue, MFL Center Tower, Suite 4100, Baltimore, MD 21224, USA +1 410 550 2003"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Medicine/Rheumatology, 55200 Eastern Avenue, MFL Center Tower, Suite 4100, Baltimore, MD 21224, USA +1 410 550 2003; +1 410 550 2072; fwig@jhmi.edu","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"+1 410 550 2072","institution_ids":[]},{"raw_affiliation_string":"Johns Hopkins University, Medicine/Rheumatology,\n55200 Eastern Avenue, MFL Center Tower, Suite 4100, Baltimore, MD 21224, USA +1 410 550 2003","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I145311948"],"apc_list":null,"apc_paid":null,"fwci":0.49,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.42149837,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"23","issue":"2","first_page":"183","last_page":"198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11310","display_name":"Connective tissue disorders research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/systemic-sclerosis","display_name":"systemic sclerosis","score":0.9169999957084656},{"id":"https://openalex.org/keywords/novel-therapeutic-agents","display_name":"novel therapeutic agents","score":0.6669999957084656},{"id":"https://openalex.org/keywords/vasculopathy","display_name":"vasculopathy","score":0.699999988079071},{"id":"https://openalex.org/keywords/autoimmunity","display_name":"autoimmunity","score":0.9929999709129333},{"id":"https://openalex.org/keywords/fibrosis","display_name":"fibrosis","score":0.9629999995231628},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9539999961853027},{"id":"https://openalex.org/keywords/tocilizumab","display_name":"tocilizumab","score":1.0},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/connective-tissue-growth-factor","display_name":"connective tissue growth factor","score":0.9049999713897705},{"id":"https://openalex.org/keywords/anti-il-13-therapy","display_name":"anti-IL-13 therapy","score":0.8659999966621399},{"id":"https://openalex.org/keywords/matricellular-proteins","display_name":"matricellular proteins","score":0.9779999852180481},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8619999885559082}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7898646593093872},{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.7803198099136353},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6293920278549194},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5124760270118713},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.493904173374176},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48817330598831177},{"id":"https://openalex.org/C2779967694","wikidata":"https://www.wikidata.org/wiki/Q1383511","display_name":"Scleroderma (fungus)","level":3,"score":0.4873548448085785},{"id":"https://openalex.org/C2911221801","wikidata":"https://www.wikidata.org/wiki/Q2742406","display_name":"Biologic Agents","level":3,"score":0.470182329416275},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4166121482849121},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33272993564605713},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24185290932655334},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.1452513337135315},{"id":"https://openalex.org/C180032290","wikidata":"https://www.wikidata.org/wiki/Q1664296","display_name":"Inoculation","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002317","descriptor_name":"Cardiovascular Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012595","descriptor_name":"Scleroderma, Systemic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012595","descriptor_name":"Scleroderma, Systemic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D036341","descriptor_name":"Intercellular Signaling Peptides and Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543784.2014.848852","doi":"https://doi.org/10.1517/13543784.2014.848852","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2014.848852","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:24261610","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24261610","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":109,"referenced_works":["https://openalex.org/W35365351","https://openalex.org/W981460048","https://openalex.org/W1490750046","https://openalex.org/W1526201307","https://openalex.org/W1963581464","https://openalex.org/W1963681955","https://openalex.org/W1964141068","https://openalex.org/W1965898519","https://openalex.org/W1966676847","https://openalex.org/W1966939472","https://openalex.org/W1970779494","https://openalex.org/W1975916512","https://openalex.org/W1981828551","https://openalex.org/W1985142412","https://openalex.org/W1991127474","https://openalex.org/W1992470642","https://openalex.org/W1994713876","https://openalex.org/W2001807095","https://openalex.org/W2005403632","https://openalex.org/W2005959847","https://openalex.org/W2006296665","https://openalex.org/W2010045652","https://openalex.org/W2011831021","https://openalex.org/W2012959199","https://openalex.org/W2013888190","https://openalex.org/W2018185237","https://openalex.org/W2020674681","https://openalex.org/W2024866056","https://openalex.org/W2026140445","https://openalex.org/W2026210060","https://openalex.org/W2027258910","https://openalex.org/W2027722116","https://openalex.org/W2027949435","https://openalex.org/W2030102084","https://openalex.org/W2033684141","https://openalex.org/W2034770517","https://openalex.org/W2037280460","https://openalex.org/W2042052097","https://openalex.org/W2042758849","https://openalex.org/W2045075118","https://openalex.org/W2051546365","https://openalex.org/W2052917153","https://openalex.org/W2055183929","https://openalex.org/W2055447043","https://openalex.org/W2056365653","https://openalex.org/W2060178740","https://openalex.org/W2061115469","https://openalex.org/W2062418628","https://openalex.org/W2063182469","https://openalex.org/W2066270582","https://openalex.org/W2068905490","https://openalex.org/W2069019259","https://openalex.org/W2071326163","https://openalex.org/W2073141218","https://openalex.org/W2076415587","https://openalex.org/W2079049219","https://openalex.org/W2088858588","https://openalex.org/W2091867969","https://openalex.org/W2095532898","https://openalex.org/W2096547558","https://openalex.org/W2098914621","https://openalex.org/W2099870577","https://openalex.org/W2105927222","https://openalex.org/W2106544674","https://openalex.org/W2108811339","https://openalex.org/W2108981404","https://openalex.org/W2110613845","https://openalex.org/W2112310459","https://openalex.org/W2115637648","https://openalex.org/W2116323280","https://openalex.org/W2117751773","https://openalex.org/W2121843378","https://openalex.org/W2125733524","https://openalex.org/W2127643187","https://openalex.org/W2131098894","https://openalex.org/W2131121772","https://openalex.org/W2132258376","https://openalex.org/W2133211977","https://openalex.org/W2135142290","https://openalex.org/W2138309359","https://openalex.org/W2140198994","https://openalex.org/W2140800784","https://openalex.org/W2141645006","https://openalex.org/W2146835805","https://openalex.org/W2149917976","https://openalex.org/W2149987257","https://openalex.org/W2152237318","https://openalex.org/W2152630825","https://openalex.org/W2153105134","https://openalex.org/W2153490433","https://openalex.org/W2156270541","https://openalex.org/W2159956880","https://openalex.org/W2161165669","https://openalex.org/W2162230936","https://openalex.org/W2163147529","https://openalex.org/W2165160668","https://openalex.org/W2165992621","https://openalex.org/W2166457225","https://openalex.org/W2169689311","https://openalex.org/W2171045928","https://openalex.org/W2171966785","https://openalex.org/W2313888666","https://openalex.org/W2316067769","https://openalex.org/W2320758849","https://openalex.org/W2342077805","https://openalex.org/W2408317903","https://openalex.org/W2431965096","https://openalex.org/W2473920310","https://openalex.org/W4296612182"],"related_works":["https://openalex.org/W3100580928","https://openalex.org/W2161165669","https://openalex.org/W2558008557","https://openalex.org/W3111460606","https://openalex.org/W2091867969","https://openalex.org/W2103133688","https://openalex.org/W2036474096","https://openalex.org/W2053721836","https://openalex.org/W2177104438","https://openalex.org/W2776328824"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1,77,137],"purpose":[2],"of":[3,27,33,50,56,71,82,85,122,155,174,181,200],"this":[4],"article":[5],"is":[6,151,184],"to":[7,100,164,196],"highlight":[8],"novel":[9,153],"therapies":[10],"that":[11,95,178],"are":[12,45,88,96,194],"being":[13,98],"used":[14,90,99],"in":[15,20,43,116,119,171,203],"scleroderma":[16],"(SSc).":[17],"Therapeutic":[18],"interventions":[19],"SSc":[21,44,103],"generally":[22],"target":[23],"at":[24],"least":[25],"one":[26],"three":[28],"ongoing":[29],"biological":[30,168],"processes":[31],"characteristic":[32],"the":[34,48,54,166,175,198],"disease:":[35],"vasculopathy,":[36],"autoimmunity":[37],"and":[38,53,111,118,134,147],"tissue":[39],"fibrosis.":[40],"Treatment":[41],"decisions":[42],"determined":[46],"by":[47],"level":[49],"disease":[51,73],"activity":[52],"degree":[55],"specific":[57],"organ":[58],"involvement.":[59],"Traditional":[60],"therapy":[61,160],"has":[62],"primarily":[63],"focused":[64],"on":[65,142,186],"organ-specific":[66],"management":[67],"without":[68],"clear":[69],"evidence":[70,177],"overall":[72],"modification.":[74],"AREAS":[75],"COVERED:":[76],"authors":[78,138],"provide":[79,140],"a":[80,83],"review":[81],"variety":[84],"agents,":[86],"which":[87,150],"already":[89],"for":[91],"other":[92],"autoimmune":[93],"diseases,":[94],"now":[97],"treat":[101],"active":[102,170],"skin":[104],"or":[105],"lung":[106],"disease,":[107],"including":[108,127],"rituximab,":[109],"tocilizumab":[110],"IVIG.":[112],"Several":[113],"agents":[114,183,202],"studied":[115],"vitro":[117],"animal":[120],"models":[121],"fibrosis":[123],"have":[124],"shown":[125],"promise,":[126],"bortezomib,":[128],"LPA-1":[129],"antagonists,":[130],"anti-CCN2":[131],"therapy,":[132],"anti-IL-13":[133],"thrombin":[135],"antagonists.":[136],"also":[139],"details":[141],"targeting":[143],"intracellular":[144],"molecular":[145],"pathways":[146],"matricellular":[148],"proteins,":[149],"another":[152],"area":[154],"investigation.":[156],"EXPERT":[157],"OPINION:":[158],"Combination":[159],"may":[161],"be":[162],"necessary":[163],"control":[165],"complex":[167],"network":[169],"SSc.":[172,205],"Most":[173],"current":[176],"suggest":[179],"benefit":[180],"these":[182,201],"based":[185],"small":[187],"population":[188],"studies.":[189],"Ultimately":[190],"well-designed":[191],"clinical":[192],"trials":[193],"required":[195],"define":[197],"role":[199],"treating":[204]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}